Division of Transplantation, Department of Surgery and.
Division of Renal Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Clin J Am Soc Nephrol. 2018 May 7;13(5):772-781. doi: 10.2215/CJN.09920917. Epub 2018 Apr 12.
Despite the important role that health care providers at dialysis facilities have in reducing racial disparities in access to kidney transplantation in the United States, little is known about provider awareness of these disparities. We aimed to evaluate health care providers' awareness of racial disparities in kidney transplant waitlisting and identify factors associated with awareness.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a cross-sectional analysis of a survey of providers from low-waitlisting dialysis facilities (=655) across all 18 ESRD networks administered in 2016 in the United States merged with 2014 US Renal Data System and 2014 US Census data. Awareness of national racial disparity in waitlisting was defined as responding "yes" to the question: "Nationally, do you think that African Americans currently have lower waitlisting rates than white patients on average?" The secondary outcome was providers' perceptions of racial difference in waitlisting at their own facilities.
Among 655 providers surveyed, 19% were aware of the national racial disparity in waitlisting: 50% (57 of 113) of medical directors, 11% (35 of 327) of nurse managers, and 16% (35 of 215) of other providers. In analyses adjusted for provider and facility characteristics, nurse managers (versus medical directors; odds ratio, 7.33; 95% confidence interval, 3.35 to 16.0) and white providers (versus black providers; odds ratio, 2.64; 95% confidence interval, 1.39 to 5.02) were more likely to be unaware of a national racial disparity in waitlisting. Facilities in the South (versus the Northeast; odds ratio, 3.05; 95% confidence interval, 1.04 to 8.94) and facilities with a low percentage of blacks (versus a high percentage of blacks; odds ratio, 1.86; 95% confidence interval, 1.02 to 3.39) were more likely to be unaware. One quarter of facilities had >5% racial difference in waitlisting within their own facilities, but only 5% were aware of the disparity.
Among a limited sample of dialysis facilities with low waitlisting, provider awareness of racial disparities in kidney transplant waitlisting was low, particularly among staff who may have more routine contact with patients.
尽管美国透析机构的医疗保健提供者在减少获取肾移植机会方面的种族差异方面发挥了重要作用,但对于提供者对这些差异的认识知之甚少。我们旨在评估医疗保健提供者对肾移植候补名单中种族差异的认识,并确定与之相关的因素。
设计、设置、参与者和测量:我们对美国所有 18 个 ESRD 网络中低候补名单透析机构的提供者进行了横断面分析(共 655 名),该分析结合了 2014 年美国肾脏数据系统和 2014 年美国人口普查数据进行了 2016 年管理的调查。对全国候补名单中种族差异的认识定义为对以下问题的回答:“在全国范围内,您是否认为非洲裔美国人目前的候补名单率平均低于白人患者?”次要结果是提供者对自己机构候补名单中种族差异的看法。
在接受调查的 655 名提供者中,有 19%意识到全国候补名单中的种族差异:50%(113 名中的 57 名)为医疗主任,11%(327 名中的 35 名)为护士经理,16%(215 名中的 35 名)为其他提供者。在调整了提供者和设施特征的分析中,与医疗主任相比,护士经理(比值比,7.33;95%置信区间,3.35 至 16.0)和白人提供者(与黑人提供者相比;比值比,2.64;95%置信区间,1.39 至 5.02)更有可能不知道候补名单中的全国种族差异。与东北部相比,南部的设施(比值比,3.05;95%置信区间,1.04 至 8.94)和黑人比例较低的设施(与黑人比例较高的设施相比;比值比,1.86;95%置信区间,1.02 至 3.39)更有可能不知道。四分之一的设施在其自身设施中存在候补名单上的种族差异>5%,但只有 5%意识到这种差异。
在候补名单较低的有限样本透析机构中,提供者对肾移植候补名单中种族差异的认识程度较低,尤其是在与患者有更常规接触的工作人员中。